Analysis: Mangalam Drugs & Organics Limited

NSE:MANGALAM Pharmaceuticals Bulk Drugs & Formulation Market cap: ₹48 cr
RS rating: 60 Stage: Stage 1

Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Mangalam Drugs & Organics Limited and 4,900+ companies.

Sign in
5-day free pass. No card required.